ChoA Pharmaceutical조아제약
034940 · KOSDAQ · ₩034940 · 조아제약
₩1,704▼ ₩4 (0.23%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 36.9% | 36.9% | 33.8% | 37.7% | 38.1% | 35.3% |
| Operating margin | −6.8% | −11.1% | −15.4% | −10.9% | −0.7% | −12.2% |
| Net margin | −4.6% | −11.5% | −15.3% | −16.7% | 0.8% | −14.0% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +3.1% | −5.4% | −0.4% | −8.6% | +19.7% | — |
| Operating income growth | +37.4% | +31.6% | −41.2% | −1,317.4% | +93.1% | — |
| Net income growth | +58.7% | +29.1% | +8.7% | −1,975.2% | +107.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −9.3% | −24.1% | −26.5% | −22.4% | 1.1% | −16.1% |
| Return on assets | −4.9% | −10.8% | −14.0% | −13.9% | 0.6% | −10.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 129.5% | 197.2% | 149.7% | 91.5% | 66.6% | 66.4% |
| Net debt to equity | 69.2% | 103.2% | 63.5% | 31.1% | 23.2% | 10.7% |
| Current ratio | 110.4% | 98.0% | 108.4% | 144.5% | 176.4% | 191.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: ChoA Pharmaceutical / 조아제약 / 034940 / KRX:034940
Source: KRX statistical information